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1. Introduction 
It has been shown earlier that treatment of purified 
Escherichia coli ribosomes with para-chloromercuri- 
benzoate (PCMB) activates their ability for transloca- 
tion in the absence of EF-G and GTP [ 1,2] . Thus, in 
the system consisting of PCMB-treated ribosomes, 
poly U and [14 C] phe-tRNA, the non-enzymatic bind- 
ing of phe-tRNA and transpeptidation are supplemented 
by non-enzymatic translocation which creates ‘non- 
enzymatic’ elongation resulting in the synthesis of 
long enough [‘4C]polyphenylalanine chains. The 
system is completely polyU-dependent, is inhibited 
by chloramphenicol, erythromycin, viridogrisein, 
tetracycline, edeine, thiostreptone, spectinomycin, 
streptomycin, kanamycin, neomycin and is not inhi- 
bited by fusidic acid [2,3] . 
It has been shown that interaction of PCMB with 
just the 30 S subparticle is completely responsible for 
the activation of the ability of the ribosome for non- 
enzymatic translocation [4]. The action of other SH- 
reagents (iodoacetamide, N-ethylmaleimide) on the 
30 S subparticle did not give such as effect and at the 
same time did not prevent the subsequent activating 
effect by PCMB [5] Since S12 was found to be the 
only protein inaccessible for the alkylating SH-reagents 
among those accessible for PCMB, the conclusion was 
made that it is the modification of the protein S12 by 
PCMB that is responsible for activation of non-enzym- 
atic translocation [S] . 
In the present communication it is shown that the 
ability for ‘non-enzymatic’ polyll-directed elongation 
and, therefore for non-enzymatic translocation in the 
ribosome is released (unblocked) by deletion of protein 
S12 from the 30 S subparticle as well as by its damage 
with PCMB. Conversely saturation of the 30 S sub- 
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particles with intact protein S12 prevents ‘non-enzym- 
atic’ translation. 
2. Materials and methods 
Ribosomal 30 S and 50 S subparticles were pre- 
pared from E. coli MRE-600 by sucrose gradient zonal 
centrifugation in the presence of 0.5 M NH4CI with 
1 mM MgCl2 [6] using the B-XV rotor of the MSE 
SS-65 centrifuge. 
The proteins were extracted from the 30 S sub- 
particles with 67% acetic acid in the presence of 0.2 M 
MgCl Z [7,8], and then fractionated on a phospho- 
cellulose column [7] . For a thorough purification from 
protein S12, the fractions adjoining the S12 peak in 
the elution profile were rechromatographed on phospho- 
cellulose and Sephadex G-l 00 columns. The composi- 
tion and purity of the fractions were controlled by 
two-dimensional polyacrylamide gel electrophoresis 
[9]. The nomenclature of Wittmann et al. was used 
to designate the proteins [IO] . 
The ribosomal 16 S RNA was obtained from the 
30 S subparticle either by removing protein with 2 M 
LiCl-4 M urea [7,11] , or by phenol deproteinization 
with 1 “/o sodium dodecyl sulphate [ 121. 
The reconstitution of the 30 S subparticles from 
16 S RNA and ribosomal protein fractions was carried 
out in a buffer 30 mM Tris-HCl - 20 mM MgClz - 
330 mM KC1 - 1 mM dithiothreito! (DTT), pH,,o 
7.4, during 1 hr at 40°C [ 131 ; the molar protein:RNA 
ratio was about 2-3 for all the proteins, except pro- 
tein S12 which was either not added (30 S [-S12] ), or 
was added at a molar ratio of about 5-6 (30 S [+S12] ). 
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Treatment of 30 S subparticles (including 30 S 
[-S12] and 30 S [+S12]) with PCMB or DTT and the 
subsequent removal of excess reagent by Sephadex 
G-SO gel-filtration were done as described earlier [4]. 
In a special experiment 50 S subparticles were 
treated with antibodies against protein S12 (anti-S12 
IgG) kindly presented by Dr G. StBffler, Max-Planck- 
Institut fiir Molekulare Genetik, Berlin. The particles 
were incubated with the anti-S12 IgG at a molar ratio 
of 1:32 for 30 min in an ice-bath [14]. 
In experiments on ‘non-enzymatic’ translation, the 
reaction mixture was prepared in a buffer with 10 mM 
Tris-HCl - 100 mM KC1 - 10 or 13 mM MgClz, 
pH,,o 7.1; 20 ~1 of the mixture contained 5 pg of 30 
S subparticles (either original 30 S or 30 S [-S12] , or 
30 S [+S12]), 10 pg of 50 S subparticles, 8-10 peg of 
polyU (K’-salt, Calbiochem) and 30 pg of total t.RNA 
containing 17- 18 pmoles of [’ 4 C] phenylalanyl- 
tRNA (the initial [’ 4 C] phenylalanine was from 
Amersham, England, 5 13 mCi/mmole); the incubation 
was done at 25’C [4,5]. When mentioned, streptomycin 
sulphate (SM) was present in the incubation mixture 
at a 5 X 10M5 or 10v4 M concentration. The radioac- 
tivity of hot trichloroacetic acid insoluble [’ 4 C] poly- 
phenylalanine was determined as described earlier [ 1, 
21. The amount of the [14 C] polyphenylalanine, ex- 
pressed in picomoles of phenylalanine residues, was 
plotted versus incubation time. 
3. Results 
3.1. ‘Non-enzymatic’ translation without treatment of 
ribosomes with PCMB 
It was observed that preparations of purified ribo- 
somal subparticles usually contain a variable fraction 
(about 20-40%) displaying an ability for non-enzym- 
atic translocation without PCMB pre-treatment (i.e., 
in the presence of DTT; see figs. in [4,5] ). In contrast 
to PCMB-activated elongation this activity was found 
to be resistant against streptomycin (fig. 1). 
There are three groups of data which can have a 
bearing on the above-mentioned observations. First, 
the resistance of ribosomes to streptomycin can be 
caused either by a mutational alteration of the ribo- 
somal protein S12 or by its complete absence in the 
30 S subparticle [ 151. Second, there is evidence that 
the protein S12 in isolated 30 S subparticles is ‘frac- 




Fig. 1. [’ 4 C] polyphenylalanine synthesis n the poly U-directed 
non-enzymatic system with the initial ribosomal subparticle 
preparation (30 S+SO S). @ - particles treated with para- 
chloromercuribenzoate (PCMB); l - particles treated with 
PCMB, streptomycin (SM) added; A - particles treated with 
dithiothreitol (DTT); A - particles treated with DTT, SM 
added. 
tional protein’, i.e., it is absent in a fraction of the 
particles [ 16,171. Third, activation of non-enzymatic 
translocation by PCMB can be due to the effect of the 
reagent simply on the protein S12 [5]. In such a case 
PCMB may destroy some function of protein S 12 ac- 
counting for blocking of non-enzymatic translocation. 
As seen in fig. 1, this does not inactivate the other 
function of the protein which provides inhibition by 
streptomycin. 
The data presented above lead to an assumption that 
the ability for non-enzymatic translocation without 
PCMB in a fraction of the ribosomal particles can be 
accounted for by the simple absence of protein S12. 
Thus, the ability for non-enzymatic translocation in the 
ribosome can be released (unblocked) both in the case 
of protein S12 damage by PCMB and in the case of 
absence of protein S12 in the ribosome; in the latter 
case the ribosomes will be streptomycin-resistant. 
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3.2. <Non-enzymatic’ translocation using the 30 S 
subparticles reconstituted in an excess of protein 
s12 
To test the above assumption we carried out experi- 
ments on the reconstitution of 30 S subparticles from 
16 S RNA and a set of ribosomal proteins with a follow- 
ing assay of the reconstituted particles in a system of 
‘non-enzymatic’ translocation. In a first series of experi- 
ments 30 S subparticles were reconstituted from a 
complete set of proteins with an excess of protein S12 
to ensure its presence in every particle. If the above- 
mentioned assumption (section 3.1) is correct, the 
non-enzymatic system with such a preparation must 
not exhibit polypeptide synthesis without PCMB 
treatment, and PCMB-activated synthesis must be 
inhibited by streptomycin. Data of one of such experi- 




Fig. 2. [’ ‘C] polyphenylalanine synthesis in the poly U-directed 
non-enzymatic system with 30 S subparticles reconstituted in 
an excess of protein S12, and with initial 50 S subparticles 
(30 S[+S12]+50 S). 
@ - reconstituted 30 S subparticles pre-treated with para- 
chloromercuribenzoate (PCMB); l - reconstituted 30 S particles 
pre-treated with PCMB, streptomycin (SM) added; a - recon- 
stituted 30 S particles pre-treated with dithiothreitol (DTT); 
A ~ reconstituted 30 S particles pre-treated with DTT, SM 
added. 
the 30 S particles with protein S12 does lead to a 
strong decrease or practical absence of the ribosome 
fraction elongating without PCMB and resistant to 
streptomycin (the activity of this fraction does not 
exceed 10% of the full activity of particles with PCMB). 
3.3. <Non-enzymatic translocation using 30 S subparti- 
cles reconstituted without protein S12 
In a second series of experiments 30 S subparticles 
were reconstituted from a set of proteins excluding 
protein S12. If the above-mentioned assumption (sec- 
tion 3.1.) and the interpretation of the previous experi- 
ment (section 3.2) are correct, the exclusion of prote- 
in S12 from the ribosome must give a system elonga- 
ting non-enzymatically without PCMB (in the presence 
of DTT), not activated by PCMB and not inhibited by 
streptomycin. The data are presented in fig. 3. It is 
seen that ribosomes reconstituted without S 12 indeed 
quite actively synthesize polyphenylalanine (about 60% 
of the full activity of the given sample of the particles) 
r 
TIME, HOURS 
Fig. 3. [ ’ ‘C] polyphenylalanine synthesis in the poly U-directed 
non-enzymatic system with 30 S subparticles reconstituted 
without protein S12, and with the initial 50 S subparticles 
(30 S[-S12] +50 S). Designations same as in fig. 2. 
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without PCMB-treatment and that this synthesis is 
streptomycin-resistant. 
However, an essential stimulation of the synthesis 
by PCMB is observed in the experiment and this stimula 
tion effect is removed by streptomycin (fig. 3). The 
latter can only indicate that despite exclusion of the 
protein S12 from the reconstituting protein mixture it 
seems to be present in some part of active ribosomes. 
There may be several reasons for this. The simplest one 
may be a contamination of original 30 S subparticles 
or their dimers in the 50 S subparticle preparations. 
That this reason does not play an essential role was 
shown in special control experiments where the 
peptide-synthesizing activity of 50 S subparticle pre- 
parations was tested in a complete (‘enzymatic’) 
polyU-directed cell-free system; according to this test 
the admixtures of functionally active 30 S subparticles 
in our 50 S subparticle preparations were not more 
than 2-3%. Sedimentation analysis also shows that 
contamination (if any) of the 30 S component in 50 S 
particle preparations does not exceed 5%. Another 
reason is the possibility of protein S12 admixtures in 
the fractions of other proteins. However, according to 
our electrophoretical analysis of the fractions, the 
admixture of protein S12 could not be more than lo%, 
while the observed effect of PCMB stimulation com- 
prises about 40% of the full activity (fig. 3). Sucrose 
gradient centrifugation analysis of the 30 S subparticles 
reconstituted without S12 and treated with anti812 
IgG according to Morrison et al. [ 181 also did not 
reveal observable aggregates or decrease of the 30 S 
peak. The third reason may be that the 50 S sub- 
particles themselves can be a source of protein S12. In- 
deed, it was recently shown that a noticeable portion 
of pure isolated 50 S subparticles can contain protein 
S12 [18]. 
To exclude at least the last of the enumerated 
sources of protein S12, we used antibodies against 
protein S12 (anti-S12 IgG). Thus, a third series of 
experiments was carried out where 30 S subparticles 
were again reconstituted without protein S 12 while 
the 50 S subparticle preparation was pre-incubated 
with antis12 IgG. The obtained 30 S subparticles 
without protein S12, pre-treated either with PCMB or 
DTT, were mixed with 50 S subparticles, still in the 
presence of anti-S1 2 IgG; then polyU and [’ 4 C] - 
phenylalanyl-tRNA were added and ‘non-enzymatic’ 
translocation was followed. The results are given in fig. 
4. It is seen that such a double exclusion of protein 
S12 from active ribosomes actually makes ‘non-enzy- 
matic’ translocation practically independent of PCMB 
treatment and streptomycin. 
5- 
XS[-Si2]+ SOS[+anti-Si2 IgG] 
TIME, HOURS 
Fig. 4. [‘4C]polyphenylalanine synthesis in the poly U-direct- 
ed non-enzymatic system with 30 S subparticles reconstituted 
without protein S12, and with 50 S subparticles treated with 
anti-S12 IgG (30 S[-S12]+50 S [+anti-S12 IgG]). Designations 
same as in fig. 2. 
4. Discussion 
Non-enzymatic translocation in the absence of 
PCMB was first reported by Pestka [ 19,201, and then 
corroborated in our laboratory [21] (see also [22,23]). 
However we encountered poor reproducibility of this 
phenomenon in various preparations of pure ribosomes 
as well as with a low activity of such non-enzymatic 
systems. The use of PCMB [l] made the system of 
‘non-enzymatic’ translocation much more active and of 
better reproducibility [23] . The data of a previous 
paper [5] and the present communication show that 
it is the protein S12 of the 30 S subparticle that has a 
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direct relation to non-enzymatic translocation: both 
its damage by PCMB and its complete deletion permits 
polyU-directed elongation in the absence of EF-T, 
EF-G and GTP. The data of this paper also indicate 
that the presence of intact protein S12 prevents such 
‘non-enzymatic’ elongation. Thus, it may be thought 
that the ribosomes in Pestka’s experiments [20,22] 
were strongly depleted of protein S12 during prepara- 
tory procedures and purification and hence displayed 
a relatively high activity in the non-enzymatic system, 
at the same time being little stimulated by p-chloro- 
mercuribenzenesulfonate (we cannot, however, exclude 
also the possibility of oxidation damage to protein S12 
during the ribosome purification process without SH- 
compounds). 
In either case the presented data indicate a previously 
unknown role of protein S12 in ribosome functioning. 
This protein prevents spontaneous (independent of 
EG-G and GTP) translocation in the ribosome. Conse- 
quently it must be in some way involved in the normal 
translocation mechanism. 
It follows that the principle ability for translocation 
in the absence of intact protein S12, EF-G and GTP 
calls for a more attentive consideration of the role of 
the ribosome proper in the translocation mechanism. 
In any case the ability to carry out a translocation 
function and its mechanism seem to be inherent to 
the basic structure of the ribosome itself while the 
role of the factors and GTP may consist only in the 
energetic and kinetic promotion (‘catalysis’) of the 
function. 
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